Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Dec 1;27(8S):S574-S577.
doi: 10.1097/RHU.0000000000000984.

Successful Treatment for Refractory Interstitial Lung Disease and Pneumomediastinum With Multidisciplinary Therapy Including Tofacitinib in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis

Manami Kato  1 , Kei Ikeda, Takahiro Kageyama, Tadamichi Kasuya, Takashi Kumagai, Hiroki Furuya, Shunsuke Furuta, Tomohiro Tamachi, Akira Suto, Kotaro Suzuki, Hiroshi Nakajima
Affiliations
Case Reports

Successful Treatment for Refractory Interstitial Lung Disease and Pneumomediastinum With Multidisciplinary Therapy Including Tofacitinib in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis

Manami Kato et al. J Clin Rheumatol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Gono T, Kuwana M. Inflammatory myopathies: choosing the right biomarkers to predict ILD in myositis. Nat Rev Rheumatol . 2016;12:504–506.
    1. Sato S, Masui K, Nishina N, et al. Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients. Rheumatology (Oxford) . 2018. doi: 10.1093/rheumatology/key060. [Epub ahead of print]. - DOI
    1. Kameda H, Nagasawa H, Ogawa H, et al. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol . 2005;32:1719–1726.
    1. Nakashima R, Hosono Y, Mimori T. Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease. Lupus . 2016;25:925–933.
    1. Nawata Y, Kurasawa K, Takabayashi K, et al. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Rheumatol . 1999;26:1527–1533.

Publication types

MeSH terms

LinkOut - more resources